Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Crimean-Congo hemorrhagic fever orthonairovirus Nucleocapsid Protein (CCHFV-NP)

Selected Variant

NCP0165-01

Size: 100 µg

Product Specifications

Background

Crimean-Congo hemorrhagic fever (CCHF) is caused by infection with a tick-borne virus (Nairovirus) in the family Bunyaviridae. The disease was first characterized in the Crimea in 1944 and given the name Crimean hemorrhagic fever. It was then later recognized in 1969 as the cause of illness in the Congo, thus resulting in the current name of the disease.Crimean-Congo hemorrhagic fever (CCHF) is caused by infection with a tick-borne virus (Nairovirus) in the family Bunyaviridae. The disease was first characterized in the Crimea in 1944 and given the name Crimean hemorrhagic fever. It was then later recognized in 1969 as the cause of illness in the Congo, thus resulting in the current name of the disease.Crimean-Congo hemorrhagic fever is found in Eastern Europe, particularly in the former Soviet Union, throughout the Mediterranean, in northwestern China, central Asia, southern Europe, Africa, the Middle East, and the Indian subcontinent.

Structure Composition

Soluble protein; PBS, PH=7.4

Swiss Prot

NM_001313894.1

Reactivity

E. coli Expression

Applications

Source of infection

Dilution

Reseach

Purity

Transferred into competent cells and the supernatant was purified by NI column affinity chromatography and the purity is > 85% (by SDS-PAGE) .

Molecular Weight

1446bp;61kDa

Storage Conditions

Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Notes

For research use only, not for use in diagnostic procedure.

Specificity

Crimean-Congo hemorrhagic fever (CCHF) is caused by infection with a tick-borne virus (Nairovirus) in the family Bunyaviridae. The disease was first characterized in the Crimea in 1944 and given the name Crimean hemorrhagic fever. It was then later recognized in 1969 as the cause of illness in the Congo, thus resulting in the current name of the disease.Crimean-Congo hemorrhagic fever (CCHF) is caused by infection with a tick-borne virus (Nairovirus) in the family Bunyaviridae. The disease was first characterized in the Crimea in 1944 and given the name Crimean hemorrhagic fever. It was then later recognized in 1969 as the cause of illness in the Congo, thus resulting in the current name of the disease.Crimean-Congo hemorrhagic fever is found in Eastern Europe, particularly in the former Soviet Union, throughout the Mediterranean, in northwestern China, central Asia, southern Europe, Africa, the Middle East, and the Indian subcontinent.

Host or Source

His-tag

Control Type

Carrier:pET30a-CCHFV-NP-His (C-term) Virus:Mus musculus high mobility group box 1 (Hmgb1)

Available Sizes

Price

Sign In for Pricing

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Anti-C21orf45/MIS18A Antibody Picoband®, HRP Conjugate
A10791-1-HRP 100 µg/Vial

Anti-C21orf45/MIS18A Antibody Picoband®, HRP Conjugate

Sign In for Pricing
View Details
CD3e (Rabbit PAb), CF647 conjugate, 0.1mg/mL
BNC470385-500 1x 500 µL

CD3e (Rabbit PAb), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Ep-CAM / CD326 (VU-1D9), Biotin conjugate, 0.1mg/mL
BNCB0017-100 1x 100 µL

Ep-CAM / CD326 (VU-1D9), Biotin conjugate, 0.1mg/mL

Sign In for Pricing
View Details
TTF-1 / NKX2.1 (8G7G3/1), CF740 conjugate, 0.1mg/mL
BNC740448-500 1x 500 µL

TTF-1 / NKX2.1 (8G7G3/1), CF740 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Anti-LRP5 Antibody Picoband®
PA2273 100 µg/Vial

Anti-LRP5 Antibody Picoband®

Sign In for Pricing
View Details